Acuitas Fights To Keep COVID-19 Biotech IP Suit Alive

By Adam Lidgett · November 1, 2023, 8:32 PM EDT

The maker of a component of a COVID-19 vaccine says a New Jersey federal court should not throw out its suit relating to two other companies' patent infringement litigation against Pfizer...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opposition

Case Information

Case Title

ACUITAS THERAPEUTICS INC. v. GENEVANT SCIENCES GMBH et al

Case Number

Court

New Jersey

Nature of Suit

Patent

Date Filed

August 04, 2023

Recent Articles By Adam

July 11, 2024
Senate Clears Patent Bill Aiming To Lower Drug Prices
June 07, 2024
DC Circ. Undoes Library Of Congress Win In Fair Use Fight
June 06, 2024
8th Circ. Affirms Cigna Noncompete Applies To CVS Hire
May 29, 2024
Greenberg Traurig Adds IP Atty From Eversheds Sutherland
May 20, 2024
Judge Tosses Acuitas' COVID Biotech IP Suit
April 30, 2024
FTC Continues To Target 'Junk' Drug Patents
April 10, 2024
Pharmacy Gets Eli Lilly's Mounjaro Suit Tossed
April 09, 2024
Endo Sues FDA Over Generic Adrenalin Approvals
March 25, 2024
Vidal Vacates Denials Of Challenges To Neo Wireless IP
March 21, 2024
Business Coalition Rebuffs Biden Plan To Seize Drug Patents